Viatris Inc (VTRS)
13.37
+0.12
(+0.91%)
USD |
NASDAQ |
Nov 22, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Viatris Debt to Equity Ratio: 0.7958 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.7957 |
June 30, 2024 | 0.876 |
March 31, 2024 | 0.8975 |
December 31, 2023 | 0.8854 |
September 30, 2023 | 0.8807 |
June 30, 2023 | 0.8925 |
March 31, 2023 | 0.8971 |
December 31, 2022 | 0.9143 |
September 30, 2022 | 1.042 |
June 30, 2022 | 1.06 |
March 31, 2022 | 1.077 |
December 31, 2021 | 1.126 |
September 30, 2021 | 1.110 |
June 30, 2021 | 1.151 |
March 31, 2021 | 1.141 |
December 31, 2020 | 1.126 |
September 30, 2020 | 0.9834 |
June 30, 2020 | 1.038 |
March 31, 2020 | 1.126 |
December 31, 2019 | 1.066 |
September 30, 2019 | 1.140 |
June 30, 2019 | 1.121 |
March 31, 2019 | 1.160 |
December 31, 2018 | 1.139 |
September 30, 2018 | 1.199 |
Date | Value |
---|---|
June 30, 2018 | 1.208 |
March 31, 2018 | 1.148 |
December 31, 2017 | 1.106 |
September 30, 2017 | 1.112 |
June 30, 2017 | 1.173 |
March 31, 2017 | 1.289 |
December 31, 2016 | 1.398 |
September 30, 2016 | 1.337 |
June 30, 2016 | 1.305 |
March 31, 2016 | 0.7276 |
December 31, 2015 | 0.7552 |
September 30, 2015 | 0.6536 |
June 30, 2015 | 0.8874 |
March 31, 2015 | 0.9402 |
December 31, 2014 | 2.612 |
September 30, 2014 | 2.386 |
June 30, 2014 | 2.467 |
March 31, 2014 | 2.585 |
December 31, 2013 | 2.730 |
September 30, 2013 | 1.961 |
June 30, 2013 | 2.124 |
March 31, 2013 | 2.181 |
December 31, 2012 | 1.716 |
September 30, 2012 | 1.486 |
June 30, 2012 | 1.780 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7957
Minimum
Sep 2024
1.151
Maximum
Jun 2021
1.004
Average
1.04
Median
Debt to Equity Ratio Benchmarks
Lexicon Pharmaceuticals Inc | 0.5596 |
Moderna Inc | 0.00 |
Baxter International Inc | 1.643 |
Gilead Sciences Inc | 1.258 |
Perspective Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 44.75B |
Total Liabilities (Quarterly) | 24.96B |
Shareholders Equity (Quarterly) | 19.79B |
Current Ratio | 1.505 |
Net Debt Paydown Yield | 4.12% |